Johnson & Johnson has released its 2018 Health for Humanity Report, detailing the company’s progress in its environmental, social and governance (ESG) focus areas: advancing better health for all, investing in people, maintaining responsible business practices, and safeguarding the environment. The annual update also includes progress made toward the Company’s Health for Humanity 2020 Goals and commitments to support United Nations Sustainable Development Goals.
The report notes
The report is available to view at http://healthforhumanityreport.jnj.com/
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.